Zhejiang Shouxiangu Pharmaceutical Co Ltd Class A 603896
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- ¥21.21
- Day Range
- ¥21.40–22.43
- 52-Week Range
- ¥18.49–44.00
- Bid/Ask
- ¥22.42 / ¥22.43
- Market Cap
- ¥4.44 Bil
- Volume/Avg
- 2.6 Mil / 1.7 Mil
Key Statistics
- Price/Earnings (Normalized)
- 17.79
- Price/Sales
- 5.45
- Dividend Yield (Trailing)
- 1.84%
- Dividend Yield (Forward)
- 1.84%
- Total Yield
- 1.84%
Company Profile
Zhejiang Shouxiangu Pharmaceutical Co Ltd is a Chinese pharmaceutical company.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Core
- Total Number of Employees
- 1,143
- Website
- http://www.sxg1909.com
Comparables
Valuation
|
Metric
|
603896
|
300142
|
688506
|
|---|---|---|---|
Price/Earnings (Normalized) | 17.79 | 59.29 | 14.52 |
Price/Book Value | 1.94 | 1.88 | 12.54 |
Price/Sales | 5.45 | 5.26 | 10.42 |
Price/Cash Flow | 11.54 | 16.40 | 14.06 |
Price/Earnings
603896
300142
688506
Financial Strength
|
Metric
|
603896
|
300142
|
688506
|
|---|---|---|---|
Quick Ratio | 3.21 | 2.51 | 2.82 |
Current Ratio | 3.70 | 2.94 | 2.97 |
Interest Coverage | 16.62 | 24.73 | 150.78 |
Quick Ratio
603896
300142
688506
Profitability
|
Metric
|
603896
|
300142
|
688506
|
|---|---|---|---|
Return on Assets (Normalized) | 7.55% | 1.93% | 121.54% |
Return on Equity (Normalized) | 11.00% | 3.16% | 223.68% |
Return on Invested Capital (Normalized) | 7.10% | 2.01% | 155.13% |
Return on Assets
603896
300142
688506
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Novo Nordisk AS ADR
NVO
| Lmpjgyztj | Mwd | $554.5 Bil | |||
| Vertex Pharmaceuticals Inc
VRTX
| Hhkslgj | Jfyyj | $119.5 Bil | |||
| Regeneron Pharmaceuticals Inc
REGN
| Gpjcwdlw | Vkzbrs | $114.6 Bil | |||
| Alnylam Pharmaceuticals Inc
ALNY
| Frkghfywf | Cbrlgh | $35.2 Bil | |||
| argenx SE ADR
ARGX
| Kjjpzbsk | Ghrx | $31.7 Bil | |||
| BioNTech SE ADR
BNTX
| Cwllkddy | Nhb | $28.0 Bil | |||
| Moderna Inc
MRNA
| Glynqcb | Zjqqn | $24.6 Bil | |||
| United Therapeutics Corp
UTHR
| Nsfvgnzqj | Cfd | $15.9 Bil | |||
| Biomarin Pharmaceutical Inc
BMRN
| Vybyhtxrd | Rycqvg | $13.4 Bil | |||
| Royalty Pharma PLC Class A
RPRX
| Yjpfhlfmm | Lgtjnll | $12.6 Bil |
United States